Written question asked by Clive Jones (Liberal Democrat) on Friday, 21 February 2025, in the House of Commons. It was due for an answer on Tuesday, 25 February 2025. It was answered by Feryal Clark (Labour) on Monday, 3 March 2025 on behalf of the Department for Science, Innovation and Technology.
AstraZeneca
- Question
-
To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 14 February to Question 29747 on AstraZeneca, if he will place a copy of the requested letter in the House of Commons Library.
- Answer
-
Due to commercial confidentiality considerations, we are unable to place the requested letter in the House of Commons Library. As with any application for Government grant funding of this nature, all cases undergo rigorous due diligence, which assesses whether the investment represents good value for money for the taxpayer.
The Government remains committed to improving the business environment for Life Sciences companies. We continue to engage positively with AstraZeneca on the new Industrial Strategy and Life Sciences Sector Plan, due to be published in late Spring. This will set out a comprehensive plan of how the Government intends to drive growth in the sector.
Secondary information
- Type
- Written question
- Reference
- 32317
- Session
- 2024-26
- Related items
- Registered interest declared
- Yes
- Subjects
- Correspondence AstraZeneca
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 21:40:05 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/32317
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/32317
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/32317